Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- China Scholarship Council
- National Institute of Diabetes and Digestive and Kidney Diseases (R00DK120875)
This publication has 89 references indexed in Scilit:
- Nonalcoholic fatty liver diseaseGastroenterology, 2002
- Clinical Features and Natural History of Nonalcoholic Steatosis SyndromesSeminars in Liver Disease, 2001
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Inter‐α‐trypsin inhibitor proteoglycan familyEuropean Journal of Biochemistry, 1998
- Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1Nature, 1997
- Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid.Journal of Biological Chemistry, 1994
- Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasionClinical & Experimental Metastasis, 1994
- Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryoCell, 1988
- cDNA Cloning of Human Inter-α-Trypsin Inhibitor Discloses Three Different ProteinsBiological Chemistry Hoppe-Seyler, 1987
- Inter‐alpha‐trypsin‐inhibitor (ITI): two distinct mRNAs in baboon liver argue for a discrete synthesis of ITI and ITI derivativesFEBS Letters, 1983